Medical device company EMVision announced on Tuesday that five of its six pivotal trial sites are now actively enrolling and scanning patients for its bedside brain scanner, marking a significant milestone in the company’s quest to revolutionise stroke diagnosis. The Sydney-based company’s emu bedside brain scanner is being tested across leading hospitals in the United…
Hanwha, Elphinstone sign contract for Redback hulls Hanwha Defence Australia (HDA) and Elphinstone have signed a contract for manufacture of “all 129 vehicle hull structures” for the Redback family of Infantry Fighting Vehicles under LAND 400 Phase 3 program. In a statement over the weekend, HDA said the work by Elphinstone under the contract is…
ASX-listed brain scanner company EMVision has announced that its First Responder Proof-of-Concept (PoC) device has been put through a series of volunteer scans in remote settings, in collaboration with the Royal Flying Doctor Service (RFDS) and the Australian Stroke Alliance. In a statement on Wednesday, the company shared that RFDS staff had received preliminary training…
Imaging company EMVision Medical Devices is preparing for a meeting with the US Food and Drug Administration as it edges closer to seeking approval to market its emu point of care scanner to detect stroke. The company has been developing a system that uses microwaves and AI in a machine small enough to fit in…
US technology company Keysight Technologies has taken a strategic stake worth $15.28 million in medical imaging company EMVision. In a statement on Thursday, EMVision said the investment represented a significant milestone, and would accelerate commercialisation of the portable brain scanner emu, its first product. Keysight will be issued 7,454,231 new ordinary shares at $2.05 per…
The calibre of nominees has been high so far, and there are only five weeks left to apply for a spot on this year’s prestigious Australia’s 50 Most Innovative Manufacturers list. This year we have profiled: EMVision, a brain scanning device manufacturer addressing the world’s second-biggest killer, stroke; Scimita Ventures, a commercialisation specialist working the…
What were the five biggest stories of the week? Here’s what visitors to this site were reading. 5) Ukraine war propels DroneShield to new records War brings no good to anyone but a few military contractors which boom during times of rising tensions – none more so than drone detection and countermeasure manufacturer DroneShield, writes…
Today we publish the first of many profiles to run as part of @AuManufacturing’s Australia’s 50 most innovative manufacturers campaign. Brent Balinski speaks to EMVision CEO Scott Kirkland about a homegrown answer to the second-biggest killer in the world. With about a quarter of all people worldwide having suffered a stroke, it’s a super-prevalent, potentially…
Brain imaging company EMVision Medical Devices has announced receipt of a $1.75 million payment under the Modern Manufacturing Initiative (MMI) grant. EMVision was awarded a grant worth $5 million in non-dilutive funding in May 2022 from the previous federal government’s MMI. The funding under the initiative’s Translation stream is to assist establishing commercial production of…
Australia-United Kingdom Free Trade Agreement takes effect The Australia-United Kingdom Free Trade Agreement (A-UKFTA) came into effect this week, eliminating export costs for some manufacturers sending goods to the United Kingdom. The A-UKFTA eliminates tariffs on over 99 per cent of Australian goods exports to the UK, including exports of wine, honey, nuts, and manufactured…